首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1624972

全球藥物依從性增強市場規模（依產品類型、治療領域、地區、範圍和預測）

Global Drug Adherence Enhancement Market Size By Type of Product, By Therapeutic Areas, By Geographic Scope And Forecast

出版日期: 2024年07月11日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

藥物依從性增強市場的規模與預測

2023 年藥物依從性增強市場價值為 33 億美元，預計到 2031 年將達到 110 億美元，2024 年至 2031 年的複合年增長率為 14.8%。

藥物依從性增強市場的全球市場推動因素

藥物依從性增強市場的發展受到多種因素的影響。

慢性病流行

隨著糖尿病、心血管疾病和呼吸系統疾病等慢性疾病在世界各地增多，對有效的藥物依從性解決方案的需求也日益增長。為了控制症狀和避免後果，這些疾病通常需要長期服藥。

老化進展：

隨著世界人口老化，對治療與年齡相關的疾病的藥物的需求日益增長。對於需要經常服用多種藥物的老人來說，堅持服藥可能很困難。可以透過使用藥物依從性強化工具來加強這些人的藥物管理。

技術開發：

穿戴式裝置、智慧型藥瓶和智慧型手機健康應用程式只是穿戴式科技如何改變藥物依從性支援的幾個例子。透過追蹤藥物攝取量、發送提醒並向患者提供回饋，這些設備提高了藥物依從率。

醫療支出：

政府和醫療保健組織致力於降低成本和改善患者的治療效果。人們正在使用藥物依從性增強解決方案，因為提高藥物依從性可以帶來更好的健康結果、更少的住院和更低的整體成本。

病患教育與意識：

強調服藥依從性的價值並向患者提供服藥依從性知識的項目可以對行為產生積極的影響。如果患者意識到不遵守醫囑的負面後果，他們將更有可能遵循醫囑。

監理措施：

越來越多的監管機構認識到服藥依從性對於改善病患預後的重要性。依從性改進解決方案是透過促進依從性的措施（例如藥物治療管理計劃）而採用的。

製藥業舉措：

為了提高用藥依從性，製藥公司正在資助開發創新藥物輸送方法和患者支援計畫等策略。透過確保患者繼續按照指示服用處方藥，這些措施有望擴大藥物依從性增強產品市場。

限制全球藥物依從性增強市場發展的因素

藥物依從性增強市場面臨多種抑制因素與課題。這些包括：

成本限制：

實施藥物依從性增強解決方案通常需要在技術、基礎設施和病患教育計畫方面進行初步投資。一些醫療保健系統，特別是發展中國家和資源貧乏地區的醫療保健系統可能無法承擔這樣的解決方案。

技術壁壘：

儘管技術不斷發展，但一些患者可能發現難以獲得或採用數位依從性解決方案，尤其是老年人和來自社會經濟弱勢家庭的患者。有限的手機、網路連線和數位素養可能會阻礙這些解決方案的有效性。

文化與行為因素：

個人行為、社會習俗和文化信仰都對人們遵守藥物治療的程度有重大影響。即使有更多的選擇，有些患者可能仍持有與藥物依從性指南相反的態度或信念，因此可能不會遵循指示。需要客製化介入措施和患者參與技術來解決行為和文化障礙。

醫療服務提供者的抵制：

醫療保健提供者可能不願意實施提高依從性的策略，因為他們懷疑幹預的有效性，擔心擾亂工作流程，或兩者兼而有之。克服 HCP 的抵抗需要強有力的證據來證明提高依從性以及將解決方案無縫整合到當前臨床工作流程中的好處。

支離破碎的醫療保健體系：

分散的醫療保健系統可能會阻礙提高藥物依從性的嘗試，其特點是醫療服務不一致、缺乏醫療協調以及醫療服務提供者之間溝通不良。如果沒有將醫生、藥劑師、護士和其他醫療專業人員聚集在一起的多學科方法，那麼在分散的醫療保健系統中提高藥物依從性將會非常困難。

監管和報銷障礙：

不同地區和醫療保健系統之間的報銷政策和監管要求不同，導致依從性解決方案難以擴展。不明確的監管準則、不一致的保險覆蓋範圍以及不支付依從性治療費用可能會阻礙對這些設備的投資並限制患者獲得治療的機會。

The market drivers for the Drug Adherence Enhancement Market can be influenced by various factors. These may include: Growing Prevalence of Chronic Diseases: There is an increasing need for efficient medication adherence solutions as chronic diseases including diabetes, cardiovascular disease, and respiratory disorders proliferate throughout the world. In order to control symptoms and avoid consequences, these illnesses frequently need for long-term medication adherence.

Growing Aging Population:

As the world's population ages, there is an increasing need for drugs to treat age-related illnesses. Adherence to many medications might be difficult for older persons who frequently need them. Medication management in this population can be enhanced with the use of drug adherence enhancement tools.

Technological Developments:

Wearables, smart pill bottles, and smartphone health apps are just a few examples of how wearable technology has transformed medication adherence support. By tracking medicine intake, sending reminders, and giving patients feedback, these devices increase adherence rates.

Expenditure on Healthcare:

Governments and healthcare institutions are concentrating more on lowering costs and enhancing patient outcomes. Adherence enhancement solutions are being used because improving medicine adherence can result in better health outcomes, fewer hospitalizations, and overall cost savings.

Patient Education and Awareness:

Programs emphasizing the value of medication adherence and providing patients with more knowledge about it can have a positive behavioral impact. Patients may be more inclined to follow their prescription regimens if they are aware of the negative effects of non-adherence.

Regulatory Initiatives:

A growing number of regulatory organizations are realizing how crucial medication adherence is to bettering patient outcomes. Adherence-enhancement solutions are being used as a result of initiatives being put in place to encourage adherence, such as drug therapy management programs.

Pharmaceutical Industry Initiatives:

In order to increase medicine adherence, pharmaceutical corporations are funding the creation of creative drug delivery methods and patient assistance initiatives, among other strategies. By ensuring that patients continue to take their prescribed drugs as directed, these initiatives hope to grow the market for drug adherence enhancement products.

Global Drug Adherence Enhancement Market Restraints

Several factors can act as restraints or challenges for the Drug Adherence Enhancement Market . These may include:

Cost Restrictions:

The initial investment in technology, infrastructure, and patient education programs is frequently necessary for the adoption of drug adherence enhancement solutions. Some healthcare systems may not be able to afford to implement these solutions, particularly those in underdeveloped nations or areas with low resources.

Technological Barriers:

Despite technological developments, certain patients may encounter difficulties utilizing and adopting digital adherence solutions, especially elderly persons or those from socioeconomically challenged families. The efficacy of these solutions may be impeded by restricted availability of cellphones, internet connectivity, or digital literacy.

Cultural and behavioral factors:

Individual behavior, social conventions, and cultural beliefs all have a big impact on how well people adhere to their medicine regimens. Even when enhanced options are available, some patients may have attitudes or ideas that conflict with adherence guidelines, which causes them to not follow the instructions. Customized interventions and patient engagement techniques are needed to address behavioral and cultural barriers.

Healthcare Provider Resistance:

Because they may be skeptical of the interventions' efficacy, worried about disrupting workflow, or both, healthcare practitioners may be reluctant to implement adherence enhancement strategies. It takes strong proof of the advantages of improving adherence as well as seamless integration of solutions into current clinical workflows to overcome provider opposition.

Fragmented Healthcare Systems:

Attempts to enhance medication adherence may be hampered by the fragmentation of healthcare systems, which is typified by inconsistent care delivery, a deficiency in care coordination, and a lack of communication between healthcare providers. It may be difficult to improve adherence in disjointed healthcare systems without a multidisciplinary approach comprising doctors, pharmacists, nurses, and other healthcare workers working together.

Obstacles related to Regulation and Reimbursement:

Different reimbursement policies and regulatory requirements exist in different areas and healthcare systems, which makes it difficult for adherence enhancement solutions to be widely used. Uncertain regulatory guidelines, inconsistent coverage, and non-payment for adherence treatments could impede investment in these devices and restrict patient access.

Global Drug Adherence Enhancement Market Segmentation Analysis

The Global Drug Adherence Enhancement Market is segmented on the basis of Type of Product, Therapeutic Areas, and Geography.

Drug Adherence Enhancement Market, By Type of Product

Smart Injectors
Smart Medication Dispensers
Smart Inhalers
Others

Based on Type of Product, The market is segmented into Smart Injectors, Smart Medication Dispensers, Smart Inhalers, and Others. Smart Injectors devices are digital devices that are reusable handheld devices loaded with a single-use syringe having a dose of injectable therapy. The patient prefilled by the manufacturer may fill it. With an automatic injector, the patient can activate the needle and subsequent drug flow by simply applying pressure to the injection site. The pressure starts the needle guard, which activates the needle guard to inject the drug. Whereas the Smart Dispenser is an automated drug dispenser that organizes, schedules, and dispenses patient medications at the push of a button. Managing multiple medications daily for patients and doctors can be overwhelming. It is a simple solution for patient medication with the touch of a button.

Drug Adherence Enhancement Market, By Therapeutic Areas

Respiratory Disorders
Cardiovascular Disorders
Metabolic Disorders
Others

Based on Therapeutic Areas, The market is segmented into Respiratory Disorders, Cardiovascular Disorders, Metabolic Disorders, and Others. Respiratory Disorders are lung diseases like asthma, cystic fibrosis, emphysema, lung cancer, mesothelioma, pulmonary hypertension, and tuberculosis. Lung disease can develop health complications, problematic symptoms, and life-threatening conditions if left untreated. In contrast, Cardiovascular Disorders main behavioral risk factors for heart disease and stroke are unhealthy diet, lack of exercise, tobacco use, and harmful alcohol intake. The effects of individual behavioral risk factors can manifest as elevated blood pressure, high blood sugar levels, elevated blood fat levels, overweight, and obesity. It has been shown to reduce the risk of cardiovascular disease by stopping tobacco, reducing dietary salt content, eating more fruits and vegetables, performing regular physical activity, and avoiding harmful alcohol intake. Health policies that create an environment that makes healthy choices available at affordable prices are essential to motivate people to adopt and maintain healthy behavior.

Drug Adherence Enhancement Market, By Geography

North America
Europe
Asia Pacific
Rest of the world
On the basis of Geography, The Global Drug Adherence Enhancement Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The North American region holds a large number of shares because of the significant players in the market. At the same time, the Asia Pacific is the fastest-growing region because of the increasing awareness about health and willingness to develop the healthcare sector in the region, which boosts the market growth of the Drug Adherence Enhancement Market.

Key Players

The "Global Drug Adherence Enhancement Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
Ventures, Abbott, AARDEX Group, 7wire Ventures, 3M, 91streets Media Technologies, 5AM, AdhereTech, ActiveCare, Abiogenix.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

1 INTRODUCTION OF GLOBAL DRUG ADHERENCE ENHANCEMENT MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL DRUG ADHERENCE ENHANCEMENT MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL DRUG ADHERENCE ENHANCEMENT MARKET, BY TYPE OF PRODUCT

5.1 Overview
5.2 Smart Injectors
5.3 Smart Medication Dispensers
5.4 Smart Inhalers
5.5 Others

6 GLOBAL DRUG ADHERENCE ENHANCEMENT MARKET, BY THERAPEUTIC AREAS

6.1 Overview
6.2 Respiratory Disorders
6.3 Cardiovascular Disorders
6.4 Metabolic Disorders
6.5 Others

7 GLOBAL DRUG ADHERENCE ENHANCEMENT MARKET, BY GEOGRAPHY

7.1 Overview
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
- 7.2.3 Mexico
7.3 Europe
- 7.3.1 Germany
- 7.3.2 U.K.
- 7.3.3 France
- 7.3.4 Rest of Europe
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Rest of Asia Pacific
7.5 Rest of the World
- 7.5.1 Latin America
- 7.5.2 Middle East Africa and Africa

8 GLOBAL DRUG ADHERENCE ENHANCEMENT MARKET COMPETITIVE LANDSCAPE

8.1 Overview
8.2 Company Market Ranking
8.3 Key Development Strategies

9 COMPANY PROFILES

9.1 Ventures
- 9.1.1 Overview
- 9.1.2 Financial Performance
- 9.1.3 Product Outlook
- 9.1.4 Key Developments
9.2 Abbott
- 9.2.1 Overview
- 9.2.2 Financial Performance
- 9.2.3 Product Outlook
- 9.2.4 Key Developments
9.3 AARDEX Group
- 9.3.1 Overview
- 9.3.2 Financial Performance
- 9.3.3 Product Outlook
- 9.3.4 Key Developments
9.4 7wire Ventures
- 9.4.1 Overview
- 9.4.2 Financial Performance
- 9.4.3 Product Outlook
- 9.4.4 Key Developments
9.5 3M
- 9.5.1 Overview
- 9.5.2 Financial Performance
- 9.5.3 Product Outlook
- 9.5.4 Key Developments
9.6 91streets Media Technologies
- 9.6.1 Overview
- 9.6.2 Financial Performance
- 9.6.3 Product Outlook
- 9.6.4 Key Developments
9.7 5AM
- 9.7.1 Overview
- 9.7.2 Financial Performance
- 9.7.3 Product Outlook
- 9.7.4 Key Developments
9.8 AdhereTech
- 9.8.1 Overview
- 9.8.2 Financial Performance
- 9.8.3 Product Outlook
- 9.8.4 Key Developments
9.9 ActiveCare
- 9.9.1 Overview
- 9.9.2 Financial Performance
- 9.9.3 Product Outlook
- 9.9.4 Key Developments
9.10 Abiogenix
- 9.10.1 Overview
- 9.10.2 Financial Performance
- 9.10.3 Product Outlook
- 9.10.4 Key Developments